Agentix Corp. (AGTX): Total Assets
$771
As of 2026-03-31
$38
As of 2026-06-30
-85.7%
3-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | $771 | -99.2% | 2026-07-01, Balance as of period end |
| 2025-03-31 | $100.3K | -5.7% | 2026-07-01, Balance as of period end |
| 2024-03-31 | $106.4K | -59.3% | 2025-07-16, Balance as of period end |
| 2023-03-31 | $261.4K | n/m | 2024-08-30, Balance as of period end |
| 2022-03-31 | $16.0K | n/a | 2023-07-14, Balance as of period end |
| 2021-08-31 | $51.2K | -82.5% | 2021-10-07, Balance as of period end |
| 2020-08-31 | $292.8K | n/m | 2021-10-07, Balance as of period end |
| 2019-08-31 | $93 | -95.9% | 2019-12-05, Balance as of period end |
| 2018-08-31 | $2.3K | -68.1% | 2019-12-05, Balance as of period end |
| 2017-08-31 | $7.1K | +451.0% | 2018-11-13, Balance as of period end |
| 2016-08-31 | $1.3K | -92.7% | 2017-12-18, Balance as of period end |
| 2015-08-31 | $17.5K | -87.4% | 2016-12-12, Balance as of period end |
| 2014-08-31 | $139.5K | n/a | 2015-12-16, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Agentix Corp. (AGTX) | 2026-03-31 | $771 | -99.2% |
| Mosaic ImmunoEngineering Inc. (CPMV) | 2025-12-31 | $19.9K | -86.0% |
| Liminatus Pharma, Inc. (LIMN) | 2025-12-31 | $512.8K | -90.5% |
| Adaptin Bio, Inc. (APTN) | 2025-12-31 | $619.2K | +158.6% |
| Brainstorm Cell Therapeutics Inc. (BCLI) | 2025-12-31 | $1.02M | -44.2% |
| Abpro Holdings, Inc. (ABPO) | 2025-12-31 | $1.06M | -77.2% |
| Zeo ScientifiX, Inc. (ZEOX) | 2025-10-31 | $1.53M | -7.1% |
| Zivo Bioscience, Inc. (ZIVO) | 2024-12-31 | $1.64M | +195.7% |
| Estrella Immunopharma, Inc. (ESLA) | 2025-12-31 | $3.18M | +1.2% |
Compare AGTX, CPMV, LIMN, APTN side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗